About
PuriBlood is a medical device company committed to improving the blood filtration and transfusion process with innovative leukoreduction technology of ‘Zwitterionic-bias Surface Coating Technology (ZISC technology)'. In conjunction with RDCMT, we hold over 36+ patents supporting our leukocyte reduction filtration mechanism. From humans to pets, we aim to bring the world a safer solution for transfusion and cell separation. To learn more about PuriBlood, visit www.puriblood.com/index.php
Technologies
GmailOutlookGoogle AppsMicrosoft Office 365Amazon AWSDigitalOceanCircle
Keywords
blood compatibilityhealthcare equipment & suppliesblood component separationblood filtration membranesbio-inert surface coatingblood filtration devicesp-tex technologymedical devicesblood compatibility coatingsblood transfusion safetymedical equipment and supplies manufacturinginterpenetrating polymer networksblood cell separationleukoreductionblood filtration researchblood cell captureblood component processingcell separationmicrobial resistancemicroorganism enrichment filtersb2bzwitterionic materialsanti-biofouling membranesbiocompatible materialsmembrane coatingwhite blood cell removalbiotechnologyblood safetyblood cell adhesion preventionhemocompatible membranes
Company Information
- Employees44
- Annual Revenue$3370000
Location
Gongye East 9th Road, Hsinchu County, Taiwan, 308
